Boston Scientific Corp. on Wednesday said it swung to a $76 million third-quarter profit, a result that narrowly beat Wall Street estimates and follows a string of recent disappointments for the medical device maker after its $27 billion acquisition of Guidant Corp.
*For more on this story,
read the full AP article.
